Similar Papers

Paper Title
Journal
Date
Author
Treatment selection bias for chemotherapy persists in colorectal cancer patient cohort studies even in comprehensive propensity score analyses.
Daniel Boakye ... Michael Hoffmeister
Clinical Epidemiology | VOL. 11
Daniel Boakye, et. al.Daniel Boakye ... Michael Hoffmeister
01 Sep 2019
CT radiomic signature to predict overall survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma.
Bolin Song ... Sarah Stock
Journal of Clinical Oncology | VOL. 41
Bolin Song, et. al.Bolin Song ... Sarah Stock
01 Jun 2023
Mucinous Histology Might Be an Indicator for Enhanced Survival Benefit of Chemotherapy in Stage II Colon Cancer.
Yong Huang ... Junfeng Chu
Frontiers in medicine | VOL. 7
Yong Huang, et. al.Yong Huang ... Junfeng Chu
05 Jun 2020
Impact of Intraoperative Tumor Spillage in Uterine Leiomyosarcoma: a Retrospective Single-Institution Analysis.
Viral Patel ... Anupama Rajanbabu
Indian journal of surgical oncology | VOL. 12
Viral Patel, et. al.Viral Patel ... Anupama Rajanbabu
07 Aug 2021
View more papers

More From: Gynecologic Oncology

Paper Title
Journal
Date
Author
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
Sara Corvigno ... Hanna Dahlstrand
Gynecologic Oncology | VOL. 193
Sara Corvigno, et. al.Sara Corvigno ... Hanna Dahlstrand
01 Feb 2025
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management.
Andrea Neilson ... Jessica N Mcalpine
Gynecologic oncology | VOL. 193
Andrea Neilson, et. al.Andrea Neilson ... Jessica N Mcalpine
01 Feb 2025
What happens after menopause? (WHAM): A prospective controlled study of cognition 24months after premenopausal risk-reducing salpingo-oophorectomy.
Pauline M Maki ... Martha Hickey
Gynecologic oncology | VOL. 193
Pauline M Maki, et. al.Pauline M Maki ... Martha Hickey
01 Feb 2025
Added prognostic value of sentinel lymph node mapping in endometrial cancer to molecular subgroups
Franziska Siegenthaler ... Michael D Mueller
Gynecologic Oncology | VOL. 193
Franziska Siegenthaler, et. al.Franziska Siegenthaler ... Michael D Mueller
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.